144 related articles for article (PubMed ID: 34268605)
1. Fractures in untreated patients with osteoporosis in Germany: an InGef healthcare insurance database analysis.
Böcker W; Doobaree IU; Khachatryan A; Dornstauder E; Bartsch R; Worth G; Singh M; Kahangire DA
Osteoporos Int; 2022 Jan; 33(1):77-86. PubMed ID: 34268605
[TBL] [Abstract][Full Text] [Related]
2. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
[TBL] [Abstract][Full Text] [Related]
3. Declining trend in osteoporosis management and screening following vertebral compression fractures - a national analysis of commercial insurance and medicare advantage beneficiaries.
Malik AT; Retchin S; Phillips FM; Xu W; Peters K; Yu E; Khan SN
Spine J; 2020 Apr; 20(4):538-546. PubMed ID: 31683068
[TBL] [Abstract][Full Text] [Related]
4. The clinical and economic burden after an osteoporosis fracture in France: a nationwide population-based study.
Fardellone P; Barnieh L; Quignot N; Gusto G; Kahangire DA; Worth G; O'Kelly J; Khachatryan A; Desamericq G
Arch Osteoporos; 2021 Aug; 16(1):124. PubMed ID: 34448084
[TBL] [Abstract][Full Text] [Related]
5. Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures.
Aguado-Maestro I; Panteli M; García-Alonso M; Bañuelos-Díaz A; Giannoudis PV
Injury; 2017 Dec; 48 Suppl 7():S27-S33. PubMed ID: 28851521
[TBL] [Abstract][Full Text] [Related]
6. Treatment rates and healthcare costs of patients with fragility fracture by site of care: a real-world data analysis.
Singer A; McClung MR; Tran O; Morrow CD; Goldstein S; Kagan R; McDermott M; Yehoshua A
Arch Osteoporos; 2023 Mar; 18(1):42. PubMed ID: 36905559
[TBL] [Abstract][Full Text] [Related]
7. Fracture risk and healthcare resource utilization and costs among osteoporosis patients with type 2 diabetes mellitus and without diabetes mellitus in Japan: retrospective analysis of a hospital claims database.
Sato M; Ye W; Sugihara T; Isaka Y
BMC Musculoskelet Disord; 2016 Nov; 17(1):489. PubMed ID: 27887655
[TBL] [Abstract][Full Text] [Related]
8. Disparities in osteoporosis treatments.
Liu Z; Weaver J; de Papp A; Li Z; Martin J; Allen K; Hui S; Imel EA
Osteoporos Int; 2016 Feb; 27(2):509-19. PubMed ID: 26216226
[TBL] [Abstract][Full Text] [Related]
9. A retrospective observational study of osteoporosis management after a fragility fracture in primary care.
Bell A; Kendler DL; Khan AA; Shapiro C M M; Morisset A; Leung JP; Reiner M; Colgan SM; Slatkovska L; Packalen M
Arch Osteoporos; 2022 May; 17(1):75. PubMed ID: 35513573
[TBL] [Abstract][Full Text] [Related]
10. Cost and consequences of noncompliance with osteoporosis treatment among women initiating therapy.
Modi A; Siris ES; Tang J; Sen S
Curr Med Res Opin; 2015 Apr; 31(4):757-65. PubMed ID: 25661017
[TBL] [Abstract][Full Text] [Related]
11. Age- and gender-specific epidemiology, treatment patterns, and economic burden of osteoporosis and associated fracture in Taiwan between 2009 and 2013.
Wang CY; Fu SH; Yang RS; Shen LJ; Wu FL; Hsiao FY
Arch Osteoporos; 2017 Oct; 12(1):92. PubMed ID: 29067572
[TBL] [Abstract][Full Text] [Related]
12. Direct healthcare costs of osteoporosis-related fractures in managed care patients receiving pharmacological osteoporosis therapy.
Viswanathan HN; Curtis JR; Yu J; White J; Stolshek BS; Merinar C; Balasubramanian A; Kallich JD; Adams JL; Wade SW
Appl Health Econ Health Policy; 2012 May; 10(3):163-73. PubMed ID: 22510025
[TBL] [Abstract][Full Text] [Related]
13. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.
Davis S; Simpson E; Hamilton J; James MM; Rawdin A; Wong R; Goka E; Gittoes N; Selby P
Health Technol Assess; 2020 Jun; 24(29):1-314. PubMed ID: 32588816
[TBL] [Abstract][Full Text] [Related]
14. Low rate of densitometric diagnosis and treatment in patients with severe osteoporosis in Colombia.
Fernández-Ávila DG; Rincón-Riaño DN; Pinzón DF; Gutiérrez Dávila JM
Arch Osteoporos; 2019 Sep; 14(1):95. PubMed ID: 31486920
[TBL] [Abstract][Full Text] [Related]
15. The Economic Burden of Severe Osteoporotic Fractures in the French Healthcare Database: The FRACTOS Study.
Thomas T; Tubach F; Bizouard G; Crochard A; Maurel F; Perrin L; Collin C; Roux C; Paccou J
J Bone Miner Res; 2022 Oct; 37(10):1811-1822. PubMed ID: 36203366
[TBL] [Abstract][Full Text] [Related]
16. Teriparatide treatment patterns in osteoporosis and subsequent fracture events: a US claims analysis.
Bonafede MM; Shi N; Bower AG; Barron RL; Grauer A; Chandler DB
Osteoporos Int; 2015 Mar; 26(3):1203-12. PubMed ID: 25567774
[TBL] [Abstract][Full Text] [Related]
17. Treatment for older men with fractures.
Shepherd AJ; Cass AR; Ray LA; Tan A; Wilkinson GS
Osteoporos Int; 2012 Mar; 23(3):1041-51. PubMed ID: 21811867
[TBL] [Abstract][Full Text] [Related]
18. Healthcare Resource Utilization and Direct Medical Costs for Patients With Osteoporotic Fractures in China.
Wu J; Qu Y; Wang K; Chen Y
Value Health Reg Issues; 2019 May; 18():106-111. PubMed ID: 30909083
[TBL] [Abstract][Full Text] [Related]
19. Utilization of osteoporosis medication after a fragility fracture among elderly Medicare beneficiaries.
Yusuf AA; Matlon TJ; Grauer A; Barron R; Chandler D; Peng Y
Arch Osteoporos; 2016 Dec; 11(1):31. PubMed ID: 27696099
[TBL] [Abstract][Full Text] [Related]
20. Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US.
Pike C; Birnbaum HG; Schiller M; Sharma H; Burge R; Edgell ET
Pharmacoeconomics; 2010; 28(5):395-409. PubMed ID: 20402541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
